Huadong Medicine Co., Ltd (SHE:000963)
33.75
-0.46 (-1.34%)
Apr 28, 2026, 3:04 PM CST
Huadong Medicine Revenue
Huadong Medicine had revenue of 11.18B CNY in the quarter ending March 31, 2026, with 4.17% growth. This brings the company's revenue in the last twelve months to 44.06B, up 4.33% year-over-year. In the year 2025, Huadong Medicine had annual revenue of 43.61B with 4.07% growth.
Revenue (ttm)
44.06B
Revenue Growth
+4.33%
P/S Ratio
1.36
Revenue / Employee
2.31M
Employees
18,265
Market Cap
60.00B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 43.61B | 1.71B | 4.07% |
| Dec 31, 2024 | 41.91B | 1.28B | 3.16% |
| Dec 31, 2023 | 40.62B | 2.91B | 7.71% |
| Jan 1, 2023 | 37.71B | 3.15B | 9.12% |
| Jan 1, 2022 | 34.56B | 880.24M | 2.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Fosun Pharmaceutical (Group) | 41.66B |
| Yunnan Baiyao Group Co.,Ltd | 41.19B |
| China Resources Sanjiu Medical & Pharmaceutical | 32.88B |
| Humanwell Healthcare (Group) | 23.96B |
| Zhejiang NHU Company | 22.25B |
| Beijing Tongrentang | 17.26B |
| Changchun High-Tech Industry (Group) | 11.67B |
| Dong-E-E-Jiao | 6.80B |
Huadong Medicine News
- 7 weeks ago - CARsgen Therapeutics Announces 2025 Annual Results - Benzinga